Hypergastrinaemia

3
Pipeline Programs
1
Companies
3
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
3
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

TM
Trio MedicinesUK - London
3 programs
3
YF476Phase 11 trial
YF476Phase 11 trial
YF476Phase 11 trial
Active Trials
NCT01699113CompletedEst. Jun 2007
NCT01601405CompletedEst. Nov 2001
NCT01601418CompletedEst. Jan 2002

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Trio MedicinesYF476
Trio MedicinesYF476
Trio MedicinesYF476

Clinical Trials (3)

NCT01699113Trio MedicinesYF476

Effects of YF476 and Rabeprazole on Gastric Function

Start: Aug 2006Est. completion: Jun 2007
Phase 1Completed
NCT01601405Trio MedicinesYF476

Effect of Repeated Doses of YF476 on Stomach Acidity

Start: Oct 2001Est. completion: Nov 2001
Phase 1Completed
NCT01601418Trio MedicinesYF476

Effect of Single Doses of YF476 on Stomach Acidity

Start: Oct 2001Est. completion: Jan 2002
Phase 1Completed

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

1 companies competing in this space